LY-900009

TypeName: Business Offer
Category:
Offer Date:2019/06/10
Country: United States
Summary: LY-900009 is a small-molecule inhibitor of Notch signalling with IC50 value of 0.27 nM via selective inhibition of the γ-secretase protein. LY-900009 was developed as a candidate therapeutic drug against AD (IDENTITY trial), which failed in phase III trials. https://www.bocsci.com/ly-900009-cas-209984-68-9-item-475540.html
Description:
OfferId: 4486
Name:Alex Brown
Telphone:
Categories